Subgroups according to BASDAI/ASDAS category (baseline)
Por um escritor misterioso
Descrição
JCM, Free Full-Text
Full article: POSTER PRESENTATIONS
Biologics Targeting, Ankylosing Spondylitis
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation
Change from baseline in BASFI, BASDAI, BASMI linear and ASDAS, and
Frontiers Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees
NNTs vs. placebo for various thresholds of improvement in BASDAI from
New evidence on the management of spondyloarthritis
Biologics Targeting, Ankylosing Spondylitis
The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications
Additional Data in Active PsA
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes
Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
